The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...
The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...
Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to ...
Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
LUND, SE / ACCESS Newswire / October 13, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX)(STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody ...
The latest update is out from Alligator Bioscience AB ( (SE:ATORX) ).
A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...
Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to ...